A Pilot Randomized Controlled Trial for Feasibility of Administering an AR Game to Postoperative Pediatric Cancer Patients
Status unconfirmed · Phase 1
Conditions studied: Pediatric Cancer, Surgery
In brief
This is a pilot study to evaluate the feasibility of SpellBound's AR (augmented reality)-enabled scavenger hunt use among 20 pediatric cancer patients undergoing surgery.
Key facts
- Study ID
- NCT04674150
- Run by
- ALTality, Inc.
- People needed
- 20
- Starts
- 2021-01-13
- Expected to finish
- 2021-11-30
- Last updated by the study team
- 2021-08-16
Who can join
Age: 3 and older, up to 18. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Ages 3-18
- English speaking parents/legal guardians and patients
- Undergoing major surgery for cancer requiring postoperative hospitalization defined as ≥2 hours of duration of surgery and requiring postoperative hospital admission of at least one night
- Expected to be prescribed postoperative inpatient opioids
- Have never taken opioids or have had no daily opioid use within the last 30 days
- Sufficient cognitive capacity to comprehend and interact with the game. This is defined as ability to utilize mobile technology (use iPad with or without assistance) and activate and respond to AR experiences within the app as determined by the clinician.
- Both child and a legal guardian are willing and able to provide informed consent.
You may not qualify if…
- History of documented peripheral neuropathy secondary to cancer treatment
- Inability to demonstrate an understanding of the game from English instructions
- Have previous played the ARISETM digital scavenger hunt game
- Any additional concerns based on the study physicians' assessments
Where it is running
- M.D. Anderson Cancer Center — Houston, Texas, United States
- Texas Children's Hospital — Houston, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.